HIV infection is associated with elevated biomarkers of immune activation in Ugandan adults with pneumonia
Autor: | Patrick Byanyima, Richard J. Wang, Rejani Lalitha, Daniela Moisi, Kristina Crothers, Michael M. Lederman, J. Lucian Davis, Sylvia Kaswabuli, Emmanuel Musisi, Abdulwahab Sessolo, Ingvar Sanyu, Peter W. Hunt, Jue Lin, Laurence Huang, William Worodria, Emily Chang, Julia Moore |
---|---|
Přispěvatelé: | Apetrei, Cristian |
Rok vydání: | 2019 |
Předmět: |
Male
RNA viruses 0301 basic medicine Pulmonology Lipopolysaccharide Receptors HIV Infections Pathology and Laboratory Medicine Biochemistry Monocytes Receptors Tumor Necrosis Factor Cohort Studies 0302 clinical medicine Immunodeficiency Viruses Heart Rate Receptors 2.1 Biological and endogenous factors Uganda Prospective Studies 030212 general & internal medicine Aetiology Hyaluronic Acid Prospective cohort study Lung Multidisciplinary biology HIV diagnosis and management Middle Aged Obstructive lung disease CD 3. Good health Infectious Diseases C-Reactive Protein Medical Microbiology Viral Pathogens Viruses Cohort Pneumonia & Influenza HIV/AIDS Infectious diseases Tuberculosis Diagnosis and Management Medicine Biomarker (medicine) Female Pathogens medicine.symptom Infection Research Article Cohort study Adult General Science & Technology Science Immunology Cardiology Inflammation Viral diseases Microbiology Fibrin Fibrinogen Degradation Products Immune Activation 03 medical and health sciences Clinical Research Antigens CD Retroviruses medicine Humans Antigens Interleukin 6 Microbial Pathogens Medicine and health sciences Interleukin-6 business.industry Inflammatory and immune system Lentivirus Immunity Organisms Biology and Life Sciences HIV Pneumonia medicine.disease 030112 virology Diagnostic medicine Good Health and Well Being Cross-Sectional Studies biology.protein Tumor Necrosis Factor business Biomarkers |
Zdroj: | PLoS ONE, Vol 14, Iss 5, p e0216680 (2019) PLoS ONE PloS one, vol 14, iss 5 |
ISSN: | 1932-6203 |
Popis: | Author(s): Wang, Richard J; Moore, Julia; Moisi, Daniela; Chang, Emily G; Byanyima, Patrick; Kaswabuli, Sylvia; Musisi, Emmanuel; Sanyu, Ingvar; Sessolo, Abdulwahab; Lalitha, Rejani; Worodria, William; Davis, J Lucian; Crothers, Kristina; Lin, Jue; Lederman, Michael M; Hunt, Peter W; Huang, Laurence | Abstract: IntroductionPneumonia is an important cause of morbidity and mortality in persons living with human immunodeficiency virus (HIV) infection. How immune activation differs among HIV-infected and HIV-uninfected adults with pneumonia is unknown.MethodsThe Inflammation, Aging, Microbes, and Obstructive Lung Disease (I AM OLD) Cohort is a prospective cohort of adults with pneumonia in Uganda. In this cross-sectional analysis, plasma was collected at pneumonia presentation to measure the following 12 biomarkers: interleukin 6 (IL-6), soluble tumor necrosis factor receptors 1 and 2 (sTNFR-1 and sTNFR-2), high sensitivity C-reactive protein (hsCRP), fibrinogen, D-dimer, soluble CD27 (sCD27), interferon gamma-inducible protein 10 (IP-10), soluble CD14 (sCD14), soluble CD163 (sCD163), hyaluronan, and intestinal fatty acid binding protein. We asked whether biomarker levels differed between HIV-infected and HIV-uninfected participants, and whether higher levels of these biomarkers were associated with mortality.ResultsOne hundred seventy-three participants were enrolled. Fifty-three percent were HIV-infected. Eight plasma biomarkers-sTNFR-1, sTNFR-2, hsCRP, D-dimer, sCD27, IP-10, sCD14, and hyaluronan-were higher among participants with HIV infection, after adjustment for pneumonia severity. Higher levels of 8 biomarkers-IL-6, sTNFR-1, sTNFR-2, hsCRP, IP-10, sCD14, sCD163, and hyaluronan-were associated with increased 2-month mortality.ConclusionsAs in other clinical contexts, HIV infection is associated with a greater degree of immune activation among Ugandan adults with pneumonia. Some of these are also associated with short-term mortality. Further study is needed to explore whether these biomarkers might predict poor long-term outcomes-such as the development of obstructive lung disease-in patients with HIV who have recovered from pneumonia. |
Databáze: | OpenAIRE |
Externí odkaz: |